Necrotizing Pancreatitis
9
1
1
4
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 9 trials
100.0%
+13.5% vs benchmark
0%
0 trials in Phase 3/4
25%
1 of 4 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 4 completed trials
Clinical Trials (9)
Organ Dysfunction Changes in Acute Necrotizing Pancreatitis Patients With Sepsis Following Open Necrosectomy
Organ Dysfunction Change in Acute Necrotizing Pancreatitis Patients With Sepsis After Open Necrosectomy
Encapsulation-oriented vs. Timing-oriented Strategies for Necrotizing Pancreatitis
ABTHERA ADVANCE™ Use Without Wittman Patch
Molecular Analysis of Microbial DNA in Infected Necrotizing Pancreatitis
Pancreatic Duct Stent for Acute Necrotizing Pancreatitis
EndoRotor DEN (Direct Endoscopic Necrosectomy)Trial
Timing of Transmural Stent Removal in Necrotizing Pancreatitis
Endoscopic Large Caliber Drainage vs. Complete Necrosectomy for Treatment of Walled-off Pancreatic Necrosis